Home > Press > SMI awarded DOE Phase II SBIR to develop p-type ZnO
SMI awarded DOE Phase II SBIR to develop p-type ZnO
Posted on February 02, 2006
Structured Materials Industries, Inc. (SMI) has been awarded a Phase II SBIR by the Department of Energy to develop p-type doping of ZnO. ZnO has shown great promise as an alternative to GaN as a blue light emitter.
Critical to demonstrating blue light emission in this material system is development of p-n junctions. While n-type material is easily achieved, p-type material has been very elusive with only a few scattered reports and with repeatability issues.
CVD is believed to be one of the best approaches to achieving p-type doping because of its ability to produce high quality films, greatly vary the chemistry and produce atomically abrupt layers when needed. For this program SMI has built a dedicated MOCVD system which it operates in-house.
About Structured Materials Industries:
Structured Materials Industries, Incorporated is focused on being the leader in Metal Organic Chemical Vapor Deposition (MOCVD) and related technologies. SMI offers for sale: systems, components, materials, and process development services. SMI has an in-house applications laboratory featuring multi-reactor deposition systems and analytic capabilities, has developed a range of strategic partnerships to develop and implement MOCVD technology and looks forward to continuing to grow and expand upon mutually advantageous relationships.
For more information, please click here.
General and Technical Information this release:
Dr. Gary S. Tompa
Structured Materials Industries, Inc.
Unit 102/103, 201 Circle Drive N.
Piscataway, New Jersey 08854
Copyright © Structured Materials Industries
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014
Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014
Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014
'Exotic' material is like a switch when super thin April 18th, 2014
Innovative strategy to facilitate organ repair April 18th, 2014
Oxford Instruments Asylum Research Introduces the MFP-3D InfinityTM AFM Featuring Powerful New Capabilities and Stunning High Performance April 18th, 2014
More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014
Scientists Capture Ultrafast Snapshots of Light-Driven Superconductivity: X-rays reveal how rapidly vanishing 'charge stripes' may be behind laser-induced high-temperature superconductivity April 16th, 2014
Aerotech X-Y ball-screw stage for economical high performance Planar positioning April 16th, 2014